[ Price : $8.95]
FDA warns Czechias Respilon Production about CGMP violations in its manufacturing of over-the-counter drugs.[ Price : $8.95]
A Bioprocess Online guest column outlines recent changes to FDAs accelerated approval pathway that were made to address systemic f...[ Price : $8.95]
TransCelerate reports on a 2025 tabletop exercise it convened with the CDER Center for Clinical Trial Innovation that focused on s...[ Price : $8.95]
New reporting reveals that FDA has withdrawn or blocked the publication of multiple internal studies supporting the safety of Covi...[ Price : $8.95]
FDA warns Orlando, FL-based Active Cosmetics Manufacturing about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA issues an untitled letter to Bayer HealthCare Pharmaceuticals, citing misleading direct-to-consumer advertising for its prosta...[ Price : $8.95]
FDA commissioner Marty Makary outlines his goals to overhaul how the agency reviews new drugs, aiming to reduce early-stage regula...[ Price : $8.95]
New Bloomberg reporting that FDA is facing mounting internal strain and external criticism just over a year into commissioner Mart...